First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria

被引：2

作者：

Niyazi, Denis ^{[1
,4
]}

Toncheva, Borislava ^{[2
,4
]}

Tonchev, Tsvetan ^{[2
,4
]}

Dzhenkov, Deyan ^{[3
,4
]}

Kalchev, Kalin ^{[3
,4
]}

Stoeva, Temenuga ^{[1
,4
]}

机构：

[1] Univ Hosp St Marina, Lab Clin Microbiol, Varna, Bulgaria

[2] Univ Hosp St Marina, Maxillofacial Surg Clin, Varna, Bulgaria

[3] Univ Hosp St Marina, Gen & Clin Pathol Clin, Varna, Bulgaria

[4] Med Univ, Varna, Bulgaria

来源：

FUTURE MICROBIOLOGY | 2022年

关键词：

Bulgaria; COVID-19; diagnosis; rhino-orbital-cerebral mucormycosis; risk factors; RHIZOPUS-ORYZAE; RHINOCEREBRAL MUCORMYCOSIS; EPIDEMIOLOGY; ZYGOMYCOSIS; FUNGI; INDIA;

D O I：

10.2217/fmb-2022-0030

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Mucormycosis is a relatively rare infection but with a high mortality rate due to the difficult and time-consuming diagnostic and therapeutic process. The authors present the first case of rhino-orbital-cerebral mucormycosis, histologically and microbiologically proven, in a patient after COVID-19 infection in Bulgaria.

引用

页码：1107 / 1113

页数：7

共 34 条

[1] The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis [J].

Ahmadikia, Kazem ;

Hashemi, Seyed Jamal ;

Khodavaisy, Sadegh ;

Getso, Muhammad Ibrahim ;

Alijani, Neda ;

Badali, Hamid ;

Mirhendi, Hossein ;

Salehi, Mohammadreza ;

Tabari, Azin ;

Mohammadi Ardehali, Mojtaba ;

Kord, Mohammad ;

Roilides, Emmanuel ;

Rezaie, Sassan .

MYCOSES, 2021, 64 (08) :798-808

[2] Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt [J].

Alfishawy, Mostafa ;

Elbendary, Amira ;

Younes, Abdelrahman ;

Negm, Ahmed ;

Hassan, Walid Shehata ;

Osman, Safinaz Hassan ;

Nassar, Mahmoud ;

Elanany, Mervat G. .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (05)

[3]

[Anonymous], 2021, SCREEN DIAGN MAN MUC

[4]

[Anonymous], 2021, ADV TIM COVID 19 SCR

[5] COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India [J].

Aranjani, Jesil Mathew ;

Manuel, Atulya ;

Abdul Razack, Habeeb Ibrahim ;

Mathew, Sam T. .

PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (11)

[6] A MECHANISM OF SUSCEPTIBILITY TO MUCORMYCOSIS IN DIABETIC-KETOACIDOSIS - TRANSFERRIN AND IRON AVAILABILITY [J].

ARTIS, WM ;

FOUNTAIN, JA ;

DELCHER, HK ;

JONES, HE .

DIABETES, 1982, 31 (12) :1109-1114

[7]

Bakathir Abdulaziz A, 2006, Sultan Qaboos Univ Med J, V6, P77

[8] MUCORMYCOSIS DURING DEFEROXAMINE THERAPY IS A SIDEROPHORE-MEDIATED INFECTION - INVITRO AND INVIVO ANIMAL STUDIES [J].

BOELAERT, JR ;

DELOCHT, M ;

VANCUTSEM, J ;

KERRELS, V ;

CANTINIEAUX, B ;

VERDONCK, A ;

VANLANDUYT, HW ;

SCHNEIDER, YJ .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :1979-1986

[9] Mucormycosis:: an emerging disease? [J].

Bouza, E. ;

Munoz, P. ;

Guinea, J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :7-23

[10] Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021 [J].

Buil, Jochem B. ;

van Zanten, Arthur R. H. ;

Bentvelsen, Robbert G. ;

Rijpstra, Tom A. ;

Goorhuis, Bram ;

van der Voort, Sanne ;

Wammes, Linda J. ;

Janson, Jeroen A. ;

Melchers, Max ;

Heusinkveld, Moniek ;

Melchers, Willem J. G. ;

Kuijper, Ed J. ;

Verweij, Paul E. .

EUROSURVEILLANCE, 2021, 26 (23)

← 1 2 3 4 →